Publications by the researcher in collaboration with Fermín Sánchez-Guijo Martín (9)

2020

  1. Inhibition of xanthine oxidoreductase enhances the potential of tyrosine kinase inhibitors against chronic myeloid leukemia

    Antioxidants, Vol. 9, Núm. 1

2019

  1. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  2. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: An alternative approach against acute myeloid leukemia

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2017

  1. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?

    Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202

  2. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry

    Cell Communication and Signaling, Vol. 14, Núm. 1

2015

  1. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles

    Leukemia Research, Vol. 39, Núm. 8, pp. 921-924

  2. PTPN13 and β-catenin regulate the quiescence of hematopoietic stem cells and their interaction with the bone marrow niche

    Stem Cell Reports, Vol. 5, Núm. 4, pp. 516-531

2014

  1. NADPH oxidases as therapeutic targets in chronic myelogenous leukemia

    Clinical Cancer Research, Vol. 20, Núm. 15, pp. 4014-4025